Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on IDT Australia.
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: 4/20 can’t help ASX cannabis companies
Health & Biotech
AstraZeneca rollout in jeopardy? The ASX’s COVID vaccine maker and wannabe seem immune
Health & Biotech
Weed Week: Oz cannabis revenue expected to double in 2021 as patients soar
Experts
ScoPo’s powerplays: His Mach7 pick paid off – will Impedimed rise as well?
News
Weekly ASX Small Cap Wrap: Who’s ready for a bubble this week?
News
There’s only one ASX stock involved in the COVID vaccine rollout right now; and it’s just dispatched the first doses
Health & Biotech
US cannabis market gets major boost as SAFE Act is put in front of legislators once again
News
Last Orders: Small caps dip 0.5%, but finish week in the green
News
Closing Bell: Today’s biggest small cap winners on the ASX
Health & Biotech
Check up: Making it in America
News
Lunchtime ASX Small Cap Wrap: Who wants to hear the good news today?
Health & Biotech
Bard1 makes Sienna an offer it can’t refuse: a $45m merger
News
This is what being on a ‘war footing’ against COVID-19 looks like
Health & Biotech
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
News
Lunchtime ASX small cap wrap: Who’s on the throne today?
Health & Biotech
Cannabis: Cann-made marijuana resin could be on the market by March
News
